Get started
Live feed
PRReleasevia Quantisnow
Galmed Pharmaceuticals Ltd. logo

Galmed Pharmaceuticals to Acquire Colospan to Create a GI-Focused Platform Targeting a $6 Billion Market

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Historical context for GLMD

Across the 13 sessions after earlier GLMD headlines, the stock closed higher 9 times and lower 4 times, with a median move of 6.3% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.

GLMD close-to-close change in the session after earlier headlines
SessionEarlier headlineGLMDSPY
Jun 2, 2026Tissue Dynamics and Galmed Unveil Unknown Metabolic Pathway for Cardiac Fibrosis and Heart Failure which Supports the Development of Aramchol for Cardiac Fibrosis-5.0%+0.1%
May 14, 2026Galmed Announces Results from First-in-Man Pharmacokinetics Study of Oral Formulation of Aramchol Meglumine (AM); 400mg AM Increases Bioavailability by ~500% in Comparison to Aramchol Free Acid (AA) 300mg+10.6%+0.8%
May 7, 2026Tissue Dynamics and Galmed Pharmaceuticals to Develop Human-Centered Chronic Cardiac Fibrosis Platform to Advance Aramchol-Based Therapeutics-0.2%-0.3%
Apr 14, 2026Galmed Announces a Collaboration Agreement with Tel Aviv University to Evaluate its SCD1 inhibitor, Aramchol, as a Targeted Therapy for Metastatic Brain Cancers-6.7%+1.2%
Apr 9, 2026Galmed Announces the Breakthrough Development of a Brain Penetrating New Formulation of its SCD1 inhibitor, Aramchol+26.2%+0.6%
Apr 1, 2026Galmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2025+8.2%+0.8%
Quantisnow market dataNASDAQ
Galmed Pharmaceuticals Ltd. logo
GLMD
Galmed Pharmaceuticals Ltd.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2014
Get push alerts for GLMD

Follow GLMD and get a push notification the moment its next story breaks.

Full GLMD profile on Quantisnow

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GLMD (Galmed Pharmaceuticals Ltd.) and more on Quantisnow.